Bill Blair
Director/Board Member chez POLAREAN IMAGING PLC
Profil
Bill Blair is currently a Non-Executive Director at North East Finance (Holdco) Ltd., a Director at North East Finance (Subco) Ltd., and an Independent Non-Executive Director at Polarean Imaging Plc.
In the past, he was the Chief Executive Officer at Adamant Ventures Ltd., an Investment Director at Excalibur Fund Managers Ltd., and a Non-Executive Director at Iksuda Therapeutics Ltd.
Postes actifs de Bill Blair
| Sociétés | Poste | Début |
|---|---|---|
| POLAREAN IMAGING PLC | Director/Board Member | 27/09/2023 |
North East Finance (Holdco) Ltd.
 North East Finance (Holdco) Ltd. Financial ConglomeratesFinance North East Finance (Holdco) Ltd. operates as a holding fund manager. It is responsible for overseeing the delivery of the program. The company is headquartered in Newcastle-upon-Tyne, the United Kingdom. | Director/Board Member | - |
North East Finance (Subco) Ltd.
 North East Finance (Subco) Ltd. Financial ConglomeratesFinance Part of NF Holdings Ltd., North East Finance (Subco) Ltd. provides investment services. The private company is based in Newcastle-upon-Tyne, UK. | Director/Board Member | - |
Anciens postes connus de Bill Blair
| Sociétés | Poste | Fin |
|---|---|---|
Iksuda Therapeutics Ltd.
 Iksuda Therapeutics Ltd. BiotechnologyHealth Technology Iksuda Therapeutics Ltd. operates as a biotechnology company which specializes in the development of next generation biotherapeutics. It creates new generation biological therapeutics through advanced glycosylation and conjugation technologies. The company has core expertise in protein/peptide fictionalization and glycosylation technologies, imparting improved pharmacokinetic properties to a broader range of biological therapeutics. It was founded by David John Simpson and Andrew Watts on November 21, 2007 and is headquartered in Newcastle upon Tyne, the United Kingdom. | Director/Board Member | 01/06/2021 |
Excalibur Fund Managers Ltd.
 Excalibur Fund Managers Ltd. Investment ManagersFinance Excalibur Fund Managers Ltd (Excalibur) is a venture capital firm founded in 1996 by Christopher Evans. The firm is headquartered in London, United Kingdom. | Corporate Officer/Principal | 01/01/2010 |
Adamant Ventures Ltd.
 Adamant Ventures Ltd. Investment ManagersFinance Adamant Ventures Ltd. (Adamant Ventures) is the UK venture capital arm of Adamant Biomedical Investments AG, owned by Zürcher Kantonalbank in Switzerland. Created in 2008, the firm is based in Edinburgh and advises the Healthcare Private Equity LP fund, investing in health care companies in the UK, Scandinavia, Central Europe and the US. | President | 22/09/2009 |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| POLAREAN IMAGING PLC | Health Technology |
| Entreprise privées | 5 |
|---|---|
Excalibur Fund Managers Ltd.
Excalibur Fund Managers Ltd. Investment ManagersFinance Excalibur Fund Managers Ltd (Excalibur) is a venture capital firm founded in 1996 by Christopher Evans. The firm is headquartered in London, United Kingdom. | Finance |
Adamant Ventures Ltd.
Adamant Ventures Ltd. Investment ManagersFinance Adamant Ventures Ltd. (Adamant Ventures) is the UK venture capital arm of Adamant Biomedical Investments AG, owned by Zürcher Kantonalbank in Switzerland. Created in 2008, the firm is based in Edinburgh and advises the Healthcare Private Equity LP fund, investing in health care companies in the UK, Scandinavia, Central Europe and the US. | Finance |
North East Finance (Holdco) Ltd.
North East Finance (Holdco) Ltd. Financial ConglomeratesFinance North East Finance (Holdco) Ltd. operates as a holding fund manager. It is responsible for overseeing the delivery of the program. The company is headquartered in Newcastle-upon-Tyne, the United Kingdom. | Finance |
Iksuda Therapeutics Ltd.
Iksuda Therapeutics Ltd. BiotechnologyHealth Technology Iksuda Therapeutics Ltd. operates as a biotechnology company which specializes in the development of next generation biotherapeutics. It creates new generation biological therapeutics through advanced glycosylation and conjugation technologies. The company has core expertise in protein/peptide fictionalization and glycosylation technologies, imparting improved pharmacokinetic properties to a broader range of biological therapeutics. It was founded by David John Simpson and Andrew Watts on November 21, 2007 and is headquartered in Newcastle upon Tyne, the United Kingdom. | Health Technology |
North East Finance (Subco) Ltd.
North East Finance (Subco) Ltd. Financial ConglomeratesFinance Part of NF Holdings Ltd., North East Finance (Subco) Ltd. provides investment services. The private company is based in Newcastle-upon-Tyne, UK. | Finance |
